Callan Family Office’s Genpact G Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$460K Sell
16,715
-13,887
-45% -$456K 0.01% 847
2026
Q1
$1.14M Buy
30,602
+4,200
+16% +$173K 0.03% 525
2025
Q4
$1.24M Buy
+26,402
New +$1.14M 0.03% 483

Other funds holding G

Callan Family Office's G Position: Q2 2026 in Review

Callan Family Office reduced its Genpact (G) stake by 45% in Q2 2026, selling an estimated $456K and leaving 16,715 shares worth $460K. The position accounts for 0.01% of the portfolio, ranked #847.

Callan Family Office first reported a position in G in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.24M in Q4 2025. 479 funds tracked by Wall St. Rank hold G as of Q2 2026.

  • Callan Family Office held 16,715 shares of Genpact worth $460K as of Q2 2026.
  • Callan Family Office sold 13,887 Genpact shares in Q2 2026, an estimated $456K.
  • Genpact made up 0.01% of Callan Family Office's portfolio in Q2 2026, its #847 holding.
  • Callan Family Office first reported a position in Genpact in Q4 2025 and has held it in 3 quarters since.
  • Callan Family Office's Genpact position peaked at $1.24M in Q4 2025.
  • 479 funds tracked by Wall St. Rank held Genpact as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.